PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript

Page 4 of 4

James Molloy : Great. Thank you for taking the questions.

Dr. Frank Bedu-Addo: No problem.

Operator: Thank you. I am showing no further questions. I’ll turn it back to Dr. Bedu-Addo for closing remarks.

Dr. Frank Bedu-Addo : Thank you very much. Before we leave, I would like to express our gratitude again to all our patients who have participated in our trials. To all our collaborators, as well as our shareholders, and also to my colleagues and our employees at PDS Biotech whose contributions have been essential in getting PDS Biotech to where we are today, with a really strong potential to take a key step to make these key advances in cancer treatment. Thank you very much again for all your time today, and I wish you all a wonderful day. Thank you very much.

Operator: This will conclude today’s conference. We disconnect your lines at this time. Thank you for your participation.

Follow Pds Biotechnology Corp (NASDAQ:PDSB)

Page 4 of 4